Full Text
ECONOMIC IMPACT OF ABOVE-LABEL DOSING WITH BIOLOGICS IN PATIENTS WITH MODERATE TO SEVERE PSORIATIC ARTHRITIS

Abstract

Authors

S. Schwartzman M. Tran Y. Li H. Zhou V. Herrera J.B. Palmer

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×